Brian Rosenberger

Insider Reports History

Location
Devon, PA
Signature
/s/ Albert P. Parker, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Brian Rosenberger:

Company Role Class Num Shares Value Price $ Report Date Ownership
Zynerba Pharmaceuticals, Inc. VP, Commercial & Business Dev. Common Stock 0 $1.33 10 Oct 2023 Direct
Zynerba Pharmaceuticals, Inc. VP, Commercial & Business Dev. Stock Option (Right to Buy) 0 10 Oct 2023 Direct

Insider Reports Filed by Brian Rosenberger

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000114036123047733-rosenberger-brian-2023-10-10 Zynerba Pharmaceuticals, Inc. 10 Oct 2023 4 $0 4 VP, Commercial & Business Dev. 11 Oct 2023, 10:05
/report/000106299323018021-rosenberger-brian-2023-09-12 Zynerba Pharmaceuticals, Inc. 12 Sep 2023 2 -$8,499 4 VP, Commercial & Business Dev. 14 Sep 2023, 16:14
/report/000089924323004446-rosenberger-brian-2023-02-07 Zynerba Pharmaceuticals, Inc. 07 Feb 2023 2 -$3,069 4 VP, Commercial & Business Dev. 09 Feb 2023, 16:20
/report/000089924323003729-rosenberger-brian-2023-01-31 Zynerba Pharmaceuticals, Inc. 31 Jan 2023 2 -$2,862 4 VP, Commercial & Business Dev. 02 Feb 2023, 19:10
/report/000106299323001385-rosenberger-brian-2023-01-23 Zynerba Pharmaceuticals, Inc. 23 Jan 2023 2 -$7,570 4 VP, Commercial & Business Dev. 25 Jan 2023, 16:26
/report/000106299322016557-rosenberger-brian-2022-07-18 Zynerba Pharmaceuticals, Inc. 18 Jul 2022 2 -$4,718 4 VP, Commercial & Business Dev. 20 Jul 2022, 16:06
/report/000106299322001782-rosenberger-brian-2022-01-26 Zynerba Pharmaceuticals, Inc. 26 Jan 2022 2 $0 4 VP, Commercial & Business Dev. 28 Jan 2022, 15:16